Sequential single cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin lymphoma
Z. G. Jackson, C. Hong, R. Schauner, B. Dropulic, P. F. Caimi, M. de Lima, K. Gupta, J. S. Reese, T. H. Hwang, D. N. Wald
The paper identifies TIGIT as a marker of CD19 CAR-T cell dysfunction in NHL patients through single-cell transcriptional and protein profiling.
bioRxiv · Apr 26, 2021Immunology